Aoxiang Pharmaceutical: Net profit of 131 million yuan in 2025, a year-on-year decrease of 36.86%

Ouxiang Pharmaceutical announced that in 2025, the operating income was 793 million yuan, a year-on-year decrease of 0.32%; net profit was 131 million yuan, a year-on-year decrease of 36.86%. The company's profit distribution plan for the year 2025 is to distribute cash dividends of 0.64 yuan per 10 shares to all shareholders, with no capital reserve capitalization or bonus share issuance for the year.